In support of a ROS/AMPK/EP300/β-catenin axis mediating glucose-induced proliferation of colon cancer cells, blockade at each level (Fig 5A) abolished the effects of glucose on proliferation. The gene discussed is EP300; the disease is colonic neoplasm.